Leukapheresis Device Market Analysis: $0.94 Billion by 2029 With a CAGR of 7.5%

Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.

Leukapheresis Device Market Value Projection: How Much Will the Market Size by 2025?
Over the past few years, the leukapheresis device market has significantly expanded. It's projected to increase from $0.65 billion in 2024 to $0.70 billion in 2025, with a compound annual growth rate (CAGR) of 7.7%. Factors such as the escalating demand for personalized medicine, the heightened focus on research and development, an increase in clinical trials, growing older population, and rising preference for minimally invasive procedures are contributing to the market's growth experienced in the historical period.

What Will Be the Market Growth Forecat for Leukapheresis Device in 2029?
In the coming years, robust expansion is anticipated in the leukapheresis device market, expected to climb to $0.94 billion by 2029 at a compound annual growth rate (CAGR) of 7.5%. This surge in the predicted phase can be credited to the rising occurrence of disorders related to blood, an upward trend in cancer cases, enhanced demand for the gathering of peripheral blood stem cells, heightened usage of leukapheresis in cellular therapies, and increasing investments in the areas of regenerative medicine and immunotherapy. Key trends during the forecast period include technological progression in apheresis devices, the inclusion of automatic and digital interfaces, advancements in handheld leukapheresis technology, upgrades in closed-circuit leukapheresis systems, and improved cell separation efficiency due to technological advancements.

Explore The Complete Report Now:
https://www.thebusinessresearchcompany.com/report/leukapheresis-device-global-market-report

What Are the Core Competitive Drivers in the Leukapheresis Device Industry?
An increase in the occurrence of blood-associated diseases is projected to stimulate the expansion of the leukapheresis device market. These disorders, which affect the composition or performance of blood cells, can lead to issues with oxygen transportation, immune reaction, or blood coagulation. The growing epidemic of blood-associated diseases can largely be attributed to an increasing elderly population, more prone to conditions like anemia, leukemia, and a variety of hematologic disorders. Leukapheresis devices are valuable in the control of these diseases, as they selectively eliminate excessive or irregular white blood cells from the bloodstream, thereby reducing symptoms and complications in conditions such as leukemia and autoimmune disorders. For example, May 2024 data from the Leukaemia Foundation, an Australian non-profit organization, showed that in 2022, about 19,403 Australians were diagnosed with blood cancers such as leukemia, lymphoma, or myeloma, equating to 53 cases per day, or one every 27 minutes. Currently, approximately 135,000 Australians are living with a blood cancer or blood disease, a figure anticipated to surpass 275,000 by 2035. Therefore, the escalating frequency of blood-related diseases is spurring the development of the leukapheresis device market.

Get Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25807&type=smp

Which Leukapheresis Device Market Segment Is Projected to See the Fastest Growth?
The leukapheresis device market covered in this report is segmented -

1) By Device Type: Therapeutic Leukapheresis, Cytapheresis, Stem Cell Collection, Research Applications, Leukapheresis Columns and Cell Separators, Leukapheresis Disposables, Apheresis Devices
2) By Component: Leukapheresis Machine, Blood Collection Set , Medical Consumables , Filters
3) By End User: Hospitals, Academic Research Institutes, Pharmaceutical And Biotechnology Companies, Blood Component Providers, Blood Centers

Subsegments:
1) By Therapeutic Leukapheresis: Leukemia Treatment Systems, Sepsis Treatment Leukapheresis Units, Autoimmune Disease Management Devices
2) By Cytapheresis: Plateletpheresis Devices, Lymphapheresis Units, Erythrocytapheresis Systems
3) By Stem Cell Collection: Peripheral Blood Stem Cell (PBSC) Collection Devices, Umbilical Cord Blood Collection Systems, Bone Marrow Stem Cell Apheresis Systems
4) By Research Applications: Cell Separation Systems for Research and Development, Clinical Trial Apheresis Platforms, Academic Laboratory Leukapheresis Devices
5) By Leukapheresis Columns And Cell Separators: Adsorption Columns, Membrane-Based Cell Separation Systems, Centrifugal Cell Separators
6) By Leukapheresis Disposables: Tubing Sets, Needles And Catheters, Collection Bags
7) By Apheresis Devices: Continuous Flow Apheresis Machines, Portable Or Mobile Apheresis Units, Intermittent Flow Apheresis Systems

Which Trends Are Opening New Opportunities in the Leukapheresis Device Market?
Leading companies in the leukapheresis device market are strategically investing in regional manufacturing capabilities to bolster accessibility to superior therapeutic devices and contribute to the achievement of local healthcare objectives. Investments in regional production lead to the creation of efficient and flexible supply chains that assure prompt delivery, reduction in import reliance, and enhanced cost-effectiveness of sophisticated blood and cell collection systems. For illustration, in November 2024, Terumo Blood and Cell Technologies, a US medical technology giant, teamed up with Terumo Medical Products (Hangzhou) Co., Ltd., a subsidiary operating out of China, to initiate localized production in Hangzhou, China. This tactical approach involved the local production of pivotal leukapheresis products such as the Trima Accel Automated Blood Collection System and the Spectra Optia Apheresis System, both of which have widespread usage in China for therapeutic apheresis, stem cell collection, and blood component separation.

Customize Your Insights And Get The Full Report Here:
https://www.thebusinessresearchcompany.com/customise?id=25807&type=smp

Who Are the Leaders in the Leukapheresis Device Market?
Major companies operating in the leukapheresis device market are Fresenius SE and Co. KGaA, Asahi Kasei Medical Co. Ltd, Baxter International Inc., Grifols S.A., TERUMO BCT INC., Kaneka Corporation, Charles River Laboratories International Inc., Mallinckrodt Pharmaceuticals, Nikkiso Co. Ltd., Haemonetics Corporation, Miltenyi Biotec GmbH, Macopharma, Precision for Medicine Inc., B. Braun Melsungen AG, BioIVT LLC, AllCells LLC, Kawasumi Laboratories Inc., Beijing Zksk Technology Co. Ltd., Puriblood Medical Co. Ltd, Medica S.p.A.

Which Regional Leukapheresis Device Markets Offer the Greatest Growth Potential?
North America was the largest region in the leukapheresis device market in 2024. The regions covered in the leukapheresis device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out to Us Speak With Our Expert: Saumya Sahay
Americas +1 310-496-7795,
Asia +44 7882 955267 & +91 8897263534,
Europe +44 7882 955267
Email: saumyas@tbrc.info
The Business Research Company - www.thebusinessresearchcompany.com
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.